Trial Profile
A multicenter, randomized, double-blind, parallel-group, placebo-controlled, active-controlled study of the efficacy and safety of sustained-release quetiapine (Seqoquel) compared with placebo in the treatment of generalized anxiety disorder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Dec 2011
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary) ; Quetiapine (Primary)
- Indications Generalised anxiety disorder
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms GOLD
- Sponsors AstraZeneca
- 06 Dec 2011 Results from a pooled analysis published in the Human Psychopharmacology: Clinical and Experimental.
- 28 Jun 2009 Planned pooled analysis of data from the GOLD, SILVER and TITANIUM trials presented at the 9th World Congress of Biological Psychiatry.
- 19 May 2009 Planned pooled analysis of data from the GOLD, SILVER and TITANIUM and PLATINUM trials presented at the 162nd Annual Meeting of the American Psychiatric Association (APA 2009).